In light of promising results of hydroxychloroquine in COVID-19, should we consider using it prophylactically in cancer patients, especially if immunocompromised?

Acknowledging that there is no time for good trials yet in this setting

Answer from: at Academic Institution

At this time, as there is no good evidence available, I would not recommend the use of hydroxycholoroquine prophylactically in cancer patients. It is unclear whether it would prevent contagion, probably not, and we still don't know if it will have any effect on the course of COVID-19. We expect ther...

Comments

Radiation Oncologist at AV Strauss MD
Thank you both for your comments. I understand tha...

at MD Anderson Cancer Center
Actually, there is some data, not great though, th...

Please select the option that best describes you:

In light of promising results of hydroxychloroquine in COVID-19, should we consider using it prophylactically in cancer patients, especially if immunocompromised?

Related Questions